Global Stem Cell Umbilical Cord Blood (UCB) Market

Global Stem Cell Umbilical Cord Blood (UCB) Market by Applications (Regenerative Medicine and Transplant Medicine), Storage Service (Private Cord Blood Banks, Public Cord Blood Banks, and Hybrid Cord Blood Banks), Therapeutics (Diabetes, Metabolic Disorders, Cancer, Immune Disorders, Blood Diseases, and Other), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028

  • Report ID: HC-4548
  • Author: Growth Market Reports
  • Rating: 4.7
  • Total Reviews: 2
  • No. Of Pages: 187
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global stem cell umbilical cord blood (UCB) market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028. After pregnancy or childbirth, cord blood is one of the richest sources of stem cells; however, this blood has enormous potential to treat chronic diseases such as cancer, diabetes, blood diseases, and immunological diseases. Stem cells derived from cord blood are utilized to treat a variety of rare diseases, including metabolic and immunological disorders.


Global Stem Cell Umbilical Cord Blood (UCB) Market summary

Market Trends, Drivers, Restraints, and Opportunities:

  • Increasing demand for cord blood for the treatment of various diseases is fueling the market.
  • Rising investments in clinical trials and research by the government and private companies is expected to drive the demand for stem cell umbilical cord blood in the coming years.
  • High competition among players is expected to hamper the market growth.
  • Prevalence of diseases among people is anticipated to provide lucrative opportunities for market players during the forecast period.

Scope of the report:

The report on stem cell umbilical cord blood (UCB) market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Stem Cell Umbilical Cord Blood (UCB) Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Applications (Regenerative Medicine and Transplant Medicine), Storage Service (Private Cord Blood Banks, Public Cord Blood Banks, and Hybrid Cord Blood Banks), Therapeutics (Diabetes, Metabolic Disorders, Cancer, Immune Disorders, Blood Diseases, and Other)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

CORDLIFE GROUP LIMITED, CBR Systems, Inc., MEDIPOST, Cryo-Cell International, Inc., Americord Registry LLC, Global Cord Blood Corporation, LifeCell International Pvt. Ltd., ViaCord, Vita 34, Mesoblast Ltd, Caladrius Biosciences, Inc. and Pluristem Inc.

Stem Cell Umbilical Cord Blood (UCB) Market Segment Insights:

The private cord blood banks segment is projected to hold significant market share

In terms of storage service, the stem cell umbilical cord blood (UCB) market can be segmented into public cord blood banks, private cord blood banks, and hybrid cord blood banks. The private cord blood banks segment held a considerable share of the market in 2020 owing to increase in use of stem cells to treat diseases and to find accurate match for transfer.

The regenerative medicine segment held substantial market share in 2020

Based on applications, the stem cell umbilical cord blood (UCB) market can be bifurcated into regenerative medicine and transplant medicine. The regenerative medicine segment constituted a significant market share in 2020 and is projected to expand at a rapid rate during the forecast period.


Global Stem Cell Umbilical Cord Blood (UCB) Market application

The diabetes segment to grow during the forecast period

On the basis of therapeutics, the market can be segregated into diabetes, metabolic disorders, cancer, immune disorders, blood diseases, and others. The diabetes segment is expected to hold a significant share of the market during the forecast period due to growing research activities in pharmaceutical and biotechnological companies and increasing patients who are suffering from diabetes which ultimately drives the market.

North America dominates the global market

In terms of regions, the global stem cell umbilical cord blood (UCB) market can be split into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America constituted a significant share of the market in 2020 due to mergers and acquisitions conducted by key market players. Moreover, increase in R&D spending by pharmaceutical and biotechnology companies and growing healthcare infrastructure in the US are driving the market in North America. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to growing R&D expenditure and government initiatives in the field of stem cell umbilical cord blood market.


Global Stem Cell Umbilical Cord Blood (UCB) Market region

Segments

Storage Service

  • Private Cord Blood Banks
  • Public Cord Blood Banks
  • Hybrid Cord Blood Banks

Applications

  • Regenerative Medicine
  • Transplant Medicine

Therapeutics

  • Diabetes
  • Metabolic Disorders
  • Cancer
  • Immune Disorders
  • Blood Diseases
  • Others

By Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

Key Players

  • CORDLIFE GROUP LIMITED
  • CBR Systems, Inc.
  • MEDIPOST
  • Cryo-Cell International, Inc.
  • Americord Registry LLC
  • Global Cord Blood Corporation
  • LifeCell International Pvt. Ltd.
  • ViaCord
  • Vita 34
  • Mesoblast Ltd
  • Caladrius Biosciences, Inc.
  • Pluristem Inc.

Competitive Landscape

Key players in the stem cell umbilical cord blood (UCB) market include CORDLIFE GROUP LIMITED, CBR Systems, Inc., MEDIPOST, Cryo-Cell International, Inc., Americord Registry LLC, Global Cord Blood Corporation, LifeCell International Pvt. Ltd., ViaCord, Vita 34, Mesoblast Ltd, Caladrius Biosciences, Inc. and Pluristem Inc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Global Stem Cell Umbilical Cord Blood (UCB) Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Stem Cell Umbilical Cord Blood (UCB) Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Stem Cell Umbilical Cord Blood (UCB) Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Stem Cell Umbilical Cord Blood (UCB) Market - Supply Chain
  4.5. Global Stem Cell Umbilical Cord Blood (UCB) Market Forecast
     4.5.1. Stem Cell Umbilical Cord Blood (UCB) Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Stem Cell Umbilical Cord Blood (UCB) Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Stem Cell Umbilical Cord Blood (UCB) Market Absolute $ Opportunity
5. Global Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
6. North America Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
7. Latin America Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
8. Europe Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
9. Asia Pacific Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
10. Middle East & Africa Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Stem Cell Umbilical Cord Blood (UCB) Market: Market Share Analysis
  11.2. Stem Cell Umbilical Cord Blood (UCB) Distributors and Customers
  11.3. Stem Cell Umbilical Cord Blood (UCB) Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. CORDLIFE GROUP LIMITED
     11.4.2. CBR Systems, Inc.
     11.4.3. MEDIPOST
     11.4.4. Cryo-Cell International, Inc.
     11.4.5. Americord Registry LLC
     11.4.6. Global Cord Blood Corporation
     11.4.7. LifeCell International Pvt. Ltd.
     11.4.8.

Storage Service

  • Private Cord Blood Banks
  • Public Cord Blood Banks
  • Hybrid Cord Blood Banks

Applications

  • Regenerative Medicine
  • Transplant Medicine

Therapeutics

  • Diabetes
  • Metabolic Disorders
  • Cancer
  • Immune Disorders
  • Blood Diseases
  • Others

By Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

Key Players

  • CORDLIFE GROUP LIMITED
  • CBR Systems, Inc.
  • MEDIPOST
  • Cryo-Cell International, Inc.
  • Americord Registry LLC
  • Global Cord Blood Corporation
  • LifeCell International Pvt. Ltd.
  • ViaCord
  • Vita 34
  • Mesoblast Ltd
  • Caladrius Biosciences, Inc.
  • Pluristem Inc.

Key players in the stem cell umbilical cord blood (UCB) market include CORDLIFE GROUP LIMITED, CBR Systems, Inc., MEDIPOST, Cryo-Cell International, Inc., Americord Registry LLC, Global Cord Blood Corporation, LifeCell International Pvt. Ltd., ViaCord, Vita 34, Mesoblast Ltd, Caladrius Biosciences, Inc. and Pluristem Inc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Global Stem Cell Umbilical Cord Blood (UCB) Market keyplayers

Buy Report